A man running on a rural road during sunset with open fields and hills in the background.

Saturday October 4th

Hustle for muscle

#RACETOENDDUCHENNE

2024 results 350+ participants & Over $40,000 raised

CLICK HERE TO REGISTER/DONATE

In our first year the Hustle for Muscle 5k raised over $40,000 for Muscular Dystrophy research and support.

We’re back for Year 2 and it’s bigger and better than ever! After an incredible first year, we’re raising the bar with even bigger goals, more ways to get involved, and new experiences for the whole family. Whether you’re running, walking, rolling, cheering, or giving, this event is your chance to make an impact and be part of something special.

We look forward to seeing you there!

The Location

Saturday, October 4th @ 8am

A glass of beer with a foamy head on a white table, inside a brewery or pub with a green and white Tall Trellis Brew Co sign in the background.

Located in Olathe, KS, Tall Trellis is a family-friendly brewpub and hopyard offering a wide selection of craft beers and a delicious food menu

Coffee and food trucks will available for purchase after the run.

25600 W Valley Pkwy, Olathe, KS 66061

Empty bar area in a restaurant with a sign that says 'Tat Tells Beer Co.' and a row of brown barstools.

Duchenne Muscular Dystrophy is a rare and progressive genetic disorder that causes muscle weakness and degeneration, primarily affecting boys. It is caused by mutations in the dystrophin gene, which is essential for muscle function. Children with DMD typically show symptoms by ages 3–5, gradually losing mobility and eventually requiring full-time care. While there is currently no cure, ongoing research offers hope. Early diagnosis, medical support, and community resources can help improve quality of life. Your support helps fund critical research, advocacy, and services for families affected by Duchenne.

All proceeds go to Parent Project Muscular Dystrophy (PPMD), a 501(c)(3) nonprofit organization dedicated to ending Duchenne.

PPMD has invested over $55 Million dollars into Duchenne research and in the last two years have contributed to the approval of 8 FDA drug approvals, with many more in development. Contributions to PPMD have a direct impact on the progression of these treatments and bettering the livelihoods for children with Duchenne.